(Utkast) Kommisjonens gjennomføringsbeslutning (EU) …/… om ikke å godkjenne visse aktive stoffer til bruk i biocidprodukter i samsvar med europaparlaments- og rådsforordning (EU) nr. 528/2012
Biocider: avslag på godkjenning av visse aktive stoffer for bruk i biocidprodukter
(Draft) Commission Implementing Decision (EU) …/… on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Utkast til kommisjonsbeslutning godkjent av komite (representanter for medlemslandene) og publisert i EUs komitologiregister 13.6.2025
Bakgrunn
(fra kommisjonsbeslutningen)
(1) Commission Delegated Regulation (EU) No 1062/20142 establishes in its Annex II a list of active substance/product-type combinations included in the review programme of existing active substances in biocidal products.
(2) For a number of active substance/product-type combinations included in that list, all the participants have withdrawn or are considered to have withdrawn their support in a timely manner.
(3) In accordance with Article 14(1) of Delegated Regulation (EU) No 1062/2014, the European Chemicals Agency (‘the Agency’) published an open invitation to take over the role of participant for those active substance/product-type combinations for which the role of participant had not previously been taken over. For those combinations no notification has been submitted to the Agency within the time limit provided for by Article 14(2) of Delegated Regulation (EU) No 1062/2014. Therefore, those active substance/product-type combinations, in accordance with Article 20, first paragraph, point (b), of that Delegated Regulation, should not be approved for use in biocidal products. Those active substance/product-type combinations are the following: (a) pyrithione zinc (product-types 2, 10); (b) reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH) (product-type 11); (c) reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH) (product-type 11).
(4) In addition, in accordance with Article 12(3) of Delegated Regulation (EU) No 1062/2014, the Agency informed the Commission of those active substance/producttype combinations for which all participants have withdrawn or are considered to have withdrawn their support in a timely manner, and for which the role of participant had previously been taken over. Those active substance/product-type combinations which, in accordance with Article 20, first paragraph, point (a), of that Delegated Regulation, should not be approved for use in biocidal products are the following: (a) 1,2-benzisothiazol-3(2H)-one (BIT) (product-type 2); (b) chlorine dioxide (product-type 12).
(5) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,